Annual report pursuant to Section 13 and 15(d)

Schedule of Accrued Expenses (Details) (Parenthetical)

v3.21.1
Schedule of Accrued Expenses (Details) (Parenthetical) - USD ($)
Dec. 31, 2020
Dec. 31, 2019
CFF Agreement [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Deferred liability $ 576,600  
Genentech Feasibility Study Agreement [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Deferred revenue $ 66,600 $ 100,000.0